SCHEMBL2949331

SCHEMBL2949331

COc1ccc2cc(-c3cnc(-c4ccccc4)o3)ccc2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.59
ALOX15 P16050 1/20 0.59
CASP1 P29466 1/20 0.59
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 2/20 0.58
HPGD P15428 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
CYP11B2 P19099 3/20 0.56
CYP11B1 P15538 2/20 0.56
RAB9A P51151 4/20 0.54
NPC1 O15118 3/20 0.54
MEN1 O00255 1/20 0.52
MITF O75030 1/20 0.52
KMT2A Q03164 1/20 0.52
PTPN1 P18031 6/20 0.51
PTPN2 P17706 1/20 0.51
CYP17A1 P05093 2/20 0.50
CYP19A1 P11511 1/20 0.50
LMNA P02545 2/20 0.47
MAPT P10636 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10909733 0.87 TSHR (0.74) TSHRALOX15CASP1KDM4EALDH1A1
SCHEMBL4875222 0.87 TSHR (0.74) TSHRALOX15CASP1KDM4EALDH1A1
SCHEMBL8411685 0.84 KDM4E (0.63) TSHRALOX15CASP1KDM4EALDH1A1
SCHEMBL5836178 0.83 KDM4E (0.68) TSHRALOX15CASP1KDM4EALDH1A1
SCHEMBL5836646 0.83 KDM4E (0.68) TSHRALOX15CASP1KDM4EALDH1A1
SCHEMBL4883708 0.81 ALOX15 (0.60) TSHRALOX15CASP1KDM4EALDH1A1
SCHEMBL2945132 0.81 TSHR (0.52) TSHRALOX15CASP1KDM4EALDH1A1
SCHEMBL1180905 0.80 KDM4E (0.72) TSHRALOX15CASP1KDM4EALDH1A1
SCHEMBL2942935 0.80 CYP11B1 (0.49) TSHRSMN1; SMN2CYP11B2CYP11B1RAB9A
SCHEMBL2943298 0.80 ALOX15 (0.63) TSHRALOX15CASP1KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7754747-B2 Oxazolo-naphthyl acids WYETH LLC (US) 2010-07-13 US disclosed
EP-1781645-A1 OXAZOLO-NAPHTHYL ACIDS AS PLASMINOGEN ACTIVATOR INHIBITOR TYPE-1(PAI-1) MODULATORS USEFUL IN THE TREATMENT OF THROMBOSIS AND CARDIOVASCULAR DISEASES Wyeth (US) 2007-05-09 EP disclosed
US-20060052348-A1 Oxazolo-naphthyl acids WYETH (US) 2006-03-09 US disclosed
WO-2006023865-A1 OXAZOLO-NAPHTHYL ACIDS AS PLAMINOGEN ACTIVATOR INHIBTOR TYPE-1 (PAI-1) MODULATORS USEFUL IN THE TREATMENT OF THROMBOSIS AND CARDIOVASCULAR DISEASES WYETH (US) 2006-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060052348-A1 Oxazolo-naphthyl acids SERPINE1, SERPINB1, SERPINC1 TSHR 1610/4885ALOX15 45/4885CASP1 901/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.